🇺🇸 FDA
Pipeline program

Sativex® (Treatment A)

GWCP1427

Phase 1 small_molecule completed

Quick answer

Sativex® (Treatment A) for Healthy Subjects is a Phase 1 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Healthy Subjects
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials